Most founders and CEOs understand bad clients. A bad client is an external pathogen; unpleasant, costly, sometimes dangerous, but ultimately containable. Your immune system can deal with it. You renegotiate the scope. You fire them. You move on.
A toxic person on your own team is a fundamentally different problem. They’re not an infection. They’re an autoimmune disorder. The organism attacks itself, can’t identify the source, and gets progressively sicker while every diagnostic comes back looking normal.
I’ve spent my career advising life sciences companies on valuation, capital structure, and the decisions that determine whether a company compounds value or quietly bleeds it. And I’ve come to believe that the single most underpriced risk in a small organization, more than market timing, more than runway, more than competitive dynamics, is the presence of a person on the team who makes trust impossible.
The Archetypes Everyone Recognizes but Nobody Prices
They come in recognizable forms.
The chronic over-promiser who delivers confident timelines that have no relationship to reality. Everything is on track. Everything is almost done. Until it isn’t, and the miss surfaces at exactly the moment you can’t absorb it; in front of a client, on a board call, the week before a filing deadline.
The pathological liar who corrupts the information environment so thoroughly that the rest of the team stops trusting any signal, from anyone. Once you know one person in the system is unreliable, the rational response is to discount everything. You get slower. You triangulate obsessively. You build redundancy where none should be needed. The whole organization gets dumber.
The charming under-performer who consumes social capital at a rate that far exceeds their productive output. Leadership likes them. Clients may like them. But the people doing the actual work know the truth, and that gap between perception and reality is where your best people start quietly updating their resumes. Not because the work is too hard, but because they’ve concluded that performance isn’t what gets rewarded at your firm.
These are far from the only patterns. There’s the credit thief, who teaches the team that collaboration is a risk because your contribution may end up wearing someone else’s name. The chaos agent, who manufactures perpetual urgency so that no one notices they’re often the one who started the fire. The splitter, who triangulates between colleagues, telling each a different version of the same conversation until factional dynamics emerge where none existed. The perpetual victim, who reframes every piece of critical feedback as persecution until the team learns it’s easier to stop giving feedback than to absorb the cost of delivering it. The gatekeeper, who hoards institutional knowledge as a power base and mistakes being a single point of failure for being indispensable. The passive saboteur, who agrees to everything in the meeting and delivers nothing afterward, creating a pattern of quiet erosion that’s almost impossible to confront because there’s never a single actionable incident.
Each of these operates through a different mechanism. But they all converge on the same outcome: the degradation of trust.
These aren’t personality quirks. They’re value destruction mechanisms. And in a small organization, five people, twelve people, twenty, the damage is amplified by proximity, interdependence and the fact that there’s nowhere to hide.
Why Small Organizations Are Especially Vulnerable
In a large institution, a toxic individual can be absorbed. They get routed around. The organization has enough redundancy, enough layers, enough alternative pathways that the damage is bounded and often invisible to leadership.
A small organization has no such buffer. Every relationship is load-bearing. Every signal matters. Every commitment carries weight precisely because there aren’t backup systems to catch failures. When someone on a five-person team misses a deadline, it doesn’t get caught by a project management layer; it lands directly on the person next to them. When someone lies about the status of a deliverable, there’s no middle management to triangulate through. The lie sits in the system until it detonates.
This is basic systems biology. In a small, tightly coupled system, perturbation doesn’t dissipate; it propagates. A bad cell in a large organism might be inconsequential. A bad cell in an embryo can be catastrophic.
The Real Cost: Trust Architecture
Here’s where most analysis of toxic team members stops short. The conventional framing is about productivity, that they don’t pull their weight, so others have to compensate. That’s true but incomplete. The far greater cost is what happens to the trust architecture of the organization.
Trust in a small team isn’t a nice-to-have. It’s infrastructure. It’s the substrate on which speed, candor, creative risk-taking and compounding collaboration all depend. When a team operates in a high-trust environment, information moves fast. People flag problems early because they’re not afraid of blame. They share half-formed ideas because they trust their colleagues to build on them rather than tear them apart. They make commitments with confidence because they know the person on the other end of the handoff will follow through.
This is what secure attachment looks like in an organizational context. And it’s the precondition for what I’d call abundance dynamics, the condition where collaboration produces more value than the sum of individual efforts, where relationships compound, where the whole system generates optionality and upside that no individual could create alone.
A toxic team member makes secure attachment impossible. And without secure attachment, you don’t get abundance. You get scarcity.
People start hoarding information. They cover their flanks. They build CYA documentation instead of building product. They optimize for individual survival rather than collective upside. The firm begins operating like a group of independent contractors sharing overhead rather than a team compounding each other’s capabilities.
The shift from abundance to scarcity dynamics is the most expensive thing that can happen to a small organization. And it’s almost always triggered by a person, not a market condition.
The Charm Problem
Of all the archetypes, the charming toxic team member is the most dangerous, specifically because they are the hardest to act on.
In biological terms, think of it this way: a healthy organism has mechanisms for identifying and eliminating cells that aren’t functioning properly. It’s called apoptosis, programmed cell death. It sounds harsh, but it’s how healthy systems maintain themselves. The dangerous pathology isn’t the cell that’s obviously broken. It’s the cell that sends false signals of health while consuming resources and suppressing the very immune response that would normally eliminate it.
Charm, in an organizational context, functions exactly this way. It’s the mechanism by which the organism is tricked into feeding a process that’s working against it. The charming underperformer generates just enough social warmth, just enough client-facing polish, just enough interpersonal goodwill to make leadership hesitate. “They’re not that bad.” “They’re going through a rough patch.” “They’re great with clients.” Meanwhile, the people closest to the work, the ones who see the missed deadlines, the shifted blame, the hollow commitments, lose faith. Not in the toxic person. In leadership’s willingness to act.
That loss of faith is the real inflection point. When good people conclude that leadership either can’t see the problem or won’t address it, they don’t usually complain. They leave. And they leave quietly, which means you don’t get the exit interview data. You get the absence.
The Compounding Equation
Small organizations that build products, serve clients and grow relationships over time are fundamentally compounding systems. The value of what you build today depends on the trust, capability and institutional knowledge you carry into tomorrow. Every relationship deepened, every process refined, every hard lesson learned and retained; these compound.
A toxic team member reverses the compounding equation. They don’t just subtract value through their own underperformance. They degrade the conditions that allow everyone else to compound. The senior analyst who would have flagged a creative solution to a client problem doesn’t speak up because last time they stuck their neck out, the charming colleague took credit. The junior team member who would have surfaced an error in a deliverable stays quiet because they’ve learned that honesty gets punished when it makes the wrong person look bad. The operations lead who would have proposed a process improvement doesn’t bother because they know the over-promiser will agree to implement it and then never follow through.
Each of these missed moments seems small in isolation. But they compound too, in the wrong direction. And after six months, twelve months, two years, you’re running a fundamentally different organization than the one you thought you were building. Not because the market changed. Not because the strategy was wrong. Because the trust substrate eroded beneath you, one missed commitment at a time.
The Decision Framework
The calculation most leaders run is: “Can we afford to lose this person?” They model the gap, the client relationships, the institutional knowledge, the transition cost, the recruitment timeline.
That’s the wrong calculation. The right calculation is: “Can we afford the compounding cost of keeping them?”
Every day a toxic team member remains in a small organization, the trust architecture degrades a little further. The best people disengage a little more. The scarcity dynamics take a little deeper hold. The organization loses a little more of its capacity to compound.
For a founder or CEO building something with long-term aspirations, a platform, a firm, a practice, the opportunity cost of tolerating toxicity isn’t measured in the quarterly performance they’re not delivering. It’s measured in the organization you’re not building while you manage around them.
Your team is your most consequential capital allocation decision. Not because of what they cost on the P&L, but because of what they make possible, or impossible, in everything else you’re trying to build.
Curate accordingly.
About RNA Advisors
RNA Advisors helps biotechnology and pharmaceutical companies translate scientific and clinical value into investor-ready narratives. Our valuation frameworks are built specifically for milestone-driven biotech—modeling phase transitions/value inflection points explicitly, aligning methodology to the actual market participants at each stage of development, and preserving the optionality that standard approaches tend to flatten. Through rigorous financial modeling, market research, and analytical frameworks built for the unique dynamics of life science assets, we bridge the gap between breakthrough science and effective capital formation.
